Home · Compare
Mayukh Sukhatme vs Trui Hebbelinck CHRO
💰 How does your salary compare?
See how you rank against the world's top executives — free, instant, SEC-backed data
Try it →
Mayukh Sukhatme earned $250.7M (22585%) more than Trui Hebbelinck CHRO in their most recent fiscal years on record.
CompanyRoivant SciencesLivaNova
TitlePresident and Chief Investment OfficerExecutive Officer
IndustryHealthcareHealthcare
Fiscal YearFY2024FY2023
Total Pay$251.9M$1.1M
Base Salary$550,000—
Stock Awards$170.2M—
Bonus$81.1M$377,873
Data Source: Figures are sourced from each executive's most recent DEF 14A proxy filing on record with the SEC. See something wrong? Report it.
ExecSalaries.com · Data sourced from SEC EDGAR DEF 14A proxy filings. · Home · About · Privacy Policy